The controlled release drug delivery market is projected to exhibit significant growth during the forecast period. Controlled release drug delivery is a form of dosage system that aids in the delivery of the drug to the patients over an extended period of time or at a specific duration. The use of these systems provides continuous delivery of medication or drug throughout the treatment of the patients. These systems make use of drug encapsulating devices from which medication or drug is released for a long period of time at a controlled rate, ranging from days to months. Controlled release drug delivery system offers several benefits including enhanced drug stability, lower dose requirement, minimal side effects, enhanced drug safety and efficacy, enhanced patient compliance, cost-effectiveness, and increased bioavailability.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/controlled-release-drug-delivery
Further, increasing awareness regarding the benefits of controlled release drug delivery systems over conventional drug delivery systems are the major factors that are driving the growth of the controlled release drug delivery market across the globe. Moreover, a controlled release drug delivery system facilitates a dose reduction that reduces the risk of overdose in older people. Extended patent protection is another major benefit offered by these systems. A patent expires 20 years from the date of filing. Certain companies will produce and sell lower-priced, generic versions of the drug after a patent expires. Such generic versions may potentially account for up to 90% of a drug’s revenues, according to the US Pharmacist, resulting in a sharp reduction in revenue for the original drug company.
A Full Report of Global Controlled Release Drug Delivery Market is Available at: https://www.omrglobal.com/industry-reports/controlled-release-drug-delivery
The additional advantage of the controlled-release drug reformulations is that the FDA approval process is shorter than it would be for a new drug as it can match the current version of the market. The key market players in the global controlled-release drug delivery market including Alza Corporation (Johnson & Johnson), Corium International Inc., Depomed, Inc., Coating Place, Inc., Pfizer Inc., and SKY Pharmaceuticals Pvt. Ltd. among others are desperately adopting new strategies to increase profitability and in line with this number of companies are bringing in the market, the modified-release formulations of existing drugs due to short pathway for approval while maintaining their market share. New product launches and geographical expansion are the key focus of major market players of the controlled-release drug delivery market.
Global Controlled Release Drug Delivery Market- Segmentation
By Type
- Metered Dose Inhalers
- Injectable
- Transdermal and Ocular Patches
- Infusion Pumps
- Oral Controlled-Drug Delivery Systems
By Technology
- Wurster technique (Drug Coating)
- Coacervation
- Micro Encapsulation
- Implants
- Transdermal
- Targeted Delivery
- Others (Liposomes)
Global Controlled Release Drug Delivery Market- Regions
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/controlled-release-drug-delivery
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
